Almirall, S.a.

This study looked at how satisfied adults with mild-to-moderate scalp psoriasis were with a prescription cream called Wynzora®. Researchers followed 291 people for 12 weeks in a real-world setting to see how the cream worked, how it affected their quality of life and itch, and ho…

This study tested whether a prescription ointment called tirbanibulin is safe and effective for treating larger areas of sun-damaged skin (actinic keratosis) on the face or scalp. It involved 280 adults who applied the ointment or a placebo cream to a defined treatment area. Rese…

This was the first study in people to test the safety of a new drug called LAD191, which is being developed for autoimmune diseases. It involved 69 healthy volunteers and people with an autoimmune condition. The main goal was to see how safe different doses were and to understand…

This study followed 331 adults with moderate-to-severe plaque psoriasis who were already using or starting the drug tildrakizumab (Ilumetri®) as part of their regular care. The goal was to see how well the treatment worked and how safe it was over nearly two years in a real-world…

This early-stage study tested the safety of an experimental drug called LAD603 in healthy adults. Researchers gave 92 participants single or multiple doses to check for side effects and see how the body absorbs and processes the medication. The main goal was to determine safe dos…